Nuvastatic 300

DRUG2 trials

Sponsors

Natureceuticals Sdn Bhd

Conditions

Breast CancerColon CancerFatigue Related to Cancer Treatment

Phase 3

Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer

RecruitingNCT07669467

Natureceuticals Sdn BhdBreast Cancer, Fatigue Related to Cancer Treatment

Start: 2025-10-01End: 2026-10-30Target: 250Updated: 2026-08-25

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.

RecruitingNCT07669454

Natureceuticals Sdn BhdColon Cancer, Fatigue Related to Cancer Treatment

Start: 2025-10-01End: 2026-11-30Target: 250Updated: 2026-06-25